GI Oncology
Conference Coverage
CRC screening rates are higher in Medicaid expansion states
Medicaid expansion may be a determinant of whether screening is even offered.
Conference Coverage
Liver transplants for CRC metastases: Coming into its own?
Transplantation is emerging as an attractive option for select patients with nonresectable CRC liver metastases, and patients with intrahepatic...
Conference Coverage
African ancestry genetically linked to worse CRC outcomes
Results from a new study provide greater clarity regarding the genetic piece of the puzzle.
News
Refined incidence rate of HCC with alcohol-associated cirrhosis encourages surveillance
Cumulative risk of HCC in patients with alcohol-associated cirrhosis was 3% after 5 years, and 9% after 10 years.
Feature
CRC blood tests: A future without screening colonoscopies?
Screening colonoscopies ultimately could be largely phased out in the years ahead in favor of highly sensitive noninvasive tests, if the blood...
From the Journals
Gene variants plus H. pylori increase risk of gastric cancer
The new findings imply that the hereditary contribution to the risk of gastric cancer is more important than previously believed.
News
Review explores the boundaries of endoscopic resection for esophageal adenocarcinoma
Technical advances are expanding the population of patients who are candidates for endoscopic resection of esophageal adenocarcinoma.
From the Journals
Does CRC risk in IBD extend to close family members?
Extra screening for CRC may not be needed for children, siblings, or parents of those with IBD, new study findings suggest.
From the Journals
Colorectal cancer incidence doubled in younger adults
Diagnoses in people younger than 55 years doubled from 1995 to 2019.
From the Journals
Pancreatic cancer incidence increases among young women in U.S.
Additional studies are needed to investigate contributing factors, particularly race and tumor characteristics.
From the Journals
Physician group issues 31 treatment recommendations for early-onset colorectal cancer
There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment.